((自动化翻译由路透提供，请见免责声明 ))
11月4日 - ** 医疗设备制造商 Revvity 股价盘前下跌 ~1.6% 至 119.05 美元
** 该公司预计 (link) 年收入介于 27.5 亿美元至 27.7 亿美元之间，低于之前预测的 27.7 亿美元至 27.9 亿美元。
** RVTY 生命科学部门第三季度营收为 3.01 亿美元，低于分析师预期的 3.0615 亿美元--数据由 LSEG 编制
** 第三季度调整后 利润为每股 1.28 美元，分析师平均预期为每股 1.13 美元。
** 有利的利润率和较低的税率使利润超预期 - TD Cowen 分析师
** 截至上次收盘，股价累计上涨 10.7
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.